StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research note released on Tuesday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of CO stock opened at $1.25 on Tuesday. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50. The stock has a market cap of $151.94 million, a P/E ratio of 1.95 and a beta of 0.16. The company has a 50 day simple moving average of $1.55 and a two-hundred day simple moving average of $1.38.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.